Foreign-Trade Zone (FTZ) 7-Mayaguez, Puerto Rico, Notification of Proposed Production Activity, Lilly del Caribe, Inc. (Pharmaceutical Products), Carolina, Puerto Rico

• Published date: 28 April 2020
• Citation: 85 FR 23505
• Record Number: 2020-08999
• Section: Notices
• Court: Foreign-trade Zones Board

Federal Register, Volume 85 Issue 82 (Tuesday, April 28, 2020)

[Federal Register Volume 85, Number 82 (Tuesday, April 28, 2020)]
                [Notices]
                [Pages 23505-23506]
                From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
                [FR Doc No: 2020-08999]
                -----------------------------------------------------------------------
                DEPARTMENT OF COMMERCE
                Foreign-Trade Zones Board
                [B-23-2020]
                Foreign-Trade Zone (FTZ) 7--Mayaguez, Puerto Rico, Notification
                of Proposed Production Activity, Lilly del Caribe, Inc. (Pharmaceutical
                Products), Carolina, Puerto Rico
                 Lilly del Caribe, Inc. (Lilly del Caribe) submitted a notification
                of proposed production activity to the FTZ Board for its facility in
                Carolina, Puerto Rico. The notification conforming to the requirements
                of the regulations of the FTZ Board (15 CFR 400.22) was received on
                April 14, 2020.
                 Lilly del Caribe already has authority to produce several active
                ingredients within Subzone 7K. The current request would add a finished
                product and a foreign-status material/component to the scope of
                authority. Pursuant to 15 CFR 400.14(b), additional FTZ authority would
                be limited to the specific foreign-status material/component and
                specific
                [[Page 23506]]
                finished product described in the submitted notification (as described
                below) and subsequently authorized by the FTZ Board.
                 Production under FTZ procedures could exempt Lilly del Caribe from
                customs duty payments on the foreign-status materials/components used
                in export production. On its domestic sales, for the foreign-status
                materials/components noted below and in the existing scope of
                authority, Lilly del Caribe would be able to choose the duty rates
                during customs entry procedures that apply to finished selpercatinib in
                dosage form (duty-free). Lilly del Caribe would be able to avoid duty
                on foreign-status components which become scrap/waste. Customs duties
                also could possibly be deferred or reduced on foreign-status production
                equipment.
                 The material/component sourced from abroad is: Selpercatinib active
                ingredient (duty rate 6.5%).
                 Public comment is invited from interested parties. Submissions
                shall be addressed to the Board's Executive Secretary and sent to:
                [email protected]. The closing period for their receipt is June 8, 2020.
                 A copy of the notification will be available for public inspection
                in the ``Reading Room'' section of the Board's website, which is
                accessible via www.trade.gov/ftz.
                 For further information, contact Christopher Wedderburn at
                [email protected] or (202) 482-1963.
                 Dated: April 22, 2020.
                Andrew McGilvray,
                Executive Secretary.
                [FR Doc. 2020-08999 Filed 4-27-20; 8:45 am]
                 BILLING CODE 3510-DS-P